Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination for use in the treatment of lung cancer

Combination for use in the treatment of lung cancer

US Patent 11304943 · Granted Apr 19, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination of cannabinoids in the treatment of leukemia2024
Priming of cancer cells with low dose naltrexone2024
Autoimmune therapy2024
Assay to identify anti-cancer agents2024
Assay to identify anti-cancer agents2024
Combination of a cannabinoid and a chemotheraopeutic agent for the treatment of 2023
Agent that increases the expression of the opioid kappa 1 for the treatment of c2022
Agent that increases the expression of the opioid kappa 1 for the treatment of c2022
Priming of cancer cells with low dose naltrexone2021
Combination of cannabinoids in the treatment of leukaemia2021
Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity i2020
Stabilized HIV-1 peptide constructs comprising the gp120 C5 domain and gp41 hydr2019